These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

460 related items for PubMed ID: 18096287

  • 1. A placebo controlled study of the propentofylline added to risperidone in chronic schizophrenia.
    Salimi S, Fotouhi A, Ghoreishi A, Derakhshan MK, Khodaie-Ardakani MR, Mohammadi MR, Noorbala AA, Ahmadi-Abhari SA, Hajiazim M, Abbasi SH, Akhondzadeh S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr 01; 32(3):726-32. PubMed ID: 18096287
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of selegiline add on therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study.
    Amiri A, Noorbala AA, Nejatisafa AA, Ghoreishi A, Derakhshan MK, Khodaie-Ardakani MR, Hajiazim M, Raznahan M, Akhondzadeh S.
    Hum Psychopharmacol; 2008 Mar 01; 23(2):79-86. PubMed ID: 17972359
    [Abstract] [Full Text] [Related]

  • 3. Effect of ritanserin, a 5HT2A/2C antagonist, on negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study.
    Akhondzadeh S, Malek-Hosseini M, Ghoreishi A, Raznahan M, Rezazadeh SA.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec 12; 32(8):1879-83. PubMed ID: 18801405
    [Abstract] [Full Text] [Related]

  • 4. Beneficial antipsychotic effects of allopurinol as add-on therapy for schizophrenia: a double blind, randomized and placebo controlled trial.
    Akhondzadeh S, Safarcherati A, Amini H.
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb 12; 29(2):253-9. PubMed ID: 15694232
    [Abstract] [Full Text] [Related]

  • 5. Adjunctive estrogen treatment in women with chronic schizophrenia: a double-blind, randomized, and placebo-controlled trial.
    Akhondzadeh S, Nejatisafa AA, Amini H, Mohammadi MR, Larijani B, Kashani L, Raisi F, Kamalipour A.
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Sep 12; 27(6):1007-12. PubMed ID: 14499318
    [Abstract] [Full Text] [Related]

  • 6. A 12-week, double-blind, placebo-controlled trial of donepezil adjunctive treatment to risperidone in chronic and stable schizophrenia.
    Akhondzadeh S, Gerami M, Noroozian M, Karamghadiri N, Ghoreishi A, Abbasi SH, Rezazadeh SA.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec 12; 32(8):1810-5. PubMed ID: 18727948
    [Abstract] [Full Text] [Related]

  • 7. Effects of warm-supplementing kidney yang (WSKY) capsule added on risperidone on cognition in chronic schizophrenic patients: a randomized, double-blind, placebo-controlled, multi-center clinical trial.
    Chen ZH, Wang GH, Wang XP, Chen RY, Wang HL, Yang MH, Huo YX, Mei HB.
    Hum Psychopharmacol; 2008 Aug 12; 23(6):465-70. PubMed ID: 18536066
    [Abstract] [Full Text] [Related]

  • 8. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients.
    Chouinard G, Jones B, Remington G, Bloom D, Addington D, MacEwan GW, Labelle A, Beauclair L, Arnott W.
    J Clin Psychopharmacol; 1993 Feb 12; 13(1):25-40. PubMed ID: 7683702
    [Abstract] [Full Text] [Related]

  • 9. Zotepine versus placebo in the treatment of schizophrenic patients with stable primary negative symptoms: a randomized double-blind multicenter trial.
    Möller HJ, Riedel M, Müller N, Fischer W, Kohnen R.
    Pharmacopsychiatry; 2004 Nov 12; 37(6):270-8. PubMed ID: 15551193
    [Abstract] [Full Text] [Related]

  • 10. Risperidone as an adjunct to clozapine therapy in chronic schizophrenics.
    Henderson DC, Goff DC.
    J Clin Psychiatry; 1996 Sep 12; 57(9):395-7. PubMed ID: 9746446
    [Abstract] [Full Text] [Related]

  • 11. Celecoxib as adjunctive therapy in schizophrenia: a double-blind, randomized and placebo-controlled trial.
    Akhondzadeh S, Tabatabaee M, Amini H, Ahmadi Abhari SA, Abbasi SH, Behnam B.
    Schizophr Res; 2007 Feb 12; 90(1-3):179-85. PubMed ID: 17208413
    [Abstract] [Full Text] [Related]

  • 12. Granisetron as an add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized double-blind placebo-controlled study.
    Khodaie-Ardakani MR, Seddighi S, Modabbernia A, Rezaei F, Salehi B, Ashrafi M, Shams-Alizadeh N, Mohammad-Karimi M, Esfandiari GR, Hajiaghaee R, Akhondzadeh S.
    J Psychiatr Res; 2013 Apr 12; 47(4):472-8. PubMed ID: 23375406
    [Abstract] [Full Text] [Related]

  • 13. Lurasidone in the treatment of acute schizophrenia: a double-blind, placebo-controlled trial.
    Nakamura M, Ogasa M, Guarino J, Phillips D, Severs J, Cucchiaro J, Loebel A.
    J Clin Psychiatry; 2009 Jun 12; 70(6):829-36. PubMed ID: 19497249
    [Abstract] [Full Text] [Related]

  • 14. Intranasal desmopressin as an adjunct to risperidone for negative symptoms of schizophrenia: a randomized, double-blind, placebo-controlled, clinical trial.
    Hosseini SM, Farokhnia M, Rezaei F, Gougol A, Yekehtaz H, Iranpour N, Salehi B, Tabrizi M, Tajdini M, Ghaleiha A, Akhondzadeh S.
    Eur Neuropsychopharmacol; 2014 Jun 12; 24(6):846-55. PubMed ID: 24636461
    [Abstract] [Full Text] [Related]

  • 15. Randomized clinical comparison of perospirone and risperidone in patients with schizophrenia: Kansai Psychiatric Multicenter Study.
    Okugawa G, Kato M, Wakeno M, Koh J, Morikawa M, Matsumoto N, Shinosaki K, Yoneda H, Kishimoto T, Kinoshita T.
    Psychiatry Clin Neurosci; 2009 Jun 12; 63(3):322-8. PubMed ID: 19566763
    [Abstract] [Full Text] [Related]

  • 16. Sildenafil adjunctive therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled trial.
    Akhondzadeh S, Ghayyoumi R, Rezaei F, Salehi B, Modabbernia AH, Maroufi A, Esfandiari GR, Naderi M, Ghebleh F, Tabrizi M, Rezazadeh SA.
    Psychopharmacology (Berl); 2011 Feb 12; 213(4):809-15. PubMed ID: 20949350
    [Abstract] [Full Text] [Related]

  • 17. The effect of mirtazapine add on therapy to risperidone in the treatment of schizophrenia: a double-blind randomized placebo-controlled trial.
    Abbasi SH, Behpournia H, Ghoreshi A, Salehi B, Raznahan M, Rezazadeh SA, Rezaei F, Akhondzadeh S.
    Schizophr Res; 2010 Feb 12; 116(2-3):101-6. PubMed ID: 19959338
    [Abstract] [Full Text] [Related]

  • 18. A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition.
    Akdede BB, Anil Yağcioğlu AE, Alptekin K, Turgut TI, Tümüklü M, Yazici MK, Jayathilake K, Tunca Z, Göğüş A, Meltzer HY.
    J Clin Psychiatry; 2006 Dec 12; 67(12):1912-9. PubMed ID: 17194269
    [Abstract] [Full Text] [Related]

  • 19. Effect of Warm-Supplementing Kidney Yang (WSKY) added to risperidone on quality of life in patients with schizophrenia: a randomized controlled trial.
    Chen ZH, Wang GH, Wang XP, Huo YX, Yang MH, Li L, Mei HB.
    Clin Rehabil; 2009 Nov 12; 23(11):963-72. PubMed ID: 19786416
    [Abstract] [Full Text] [Related]

  • 20. Clinical evaluation of risperidone in Asian patients with schizophrenia in Singapore.
    Chong SA, Yap HL, Low BL, Choo CH, Chan AO, Wong KE, Mahendran R, Chee KT.
    Singapore Med J; 1999 Jan 12; 40(1):41-3. PubMed ID: 10361485
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.